Gfp - maybe that's the answer, Cornell wins either way. If the trials are good, they win by exercising at .9x while the stock goes to $3 (or whatever it hits). If the trials fail, Cornell shorts the company out of existence and never has to cover their shorts. It wouldn't surprise me if Cornell would also be at the front of the line for creditors as well after the bankruptcy. :^)